Alphabiome.ai
Alphabiome uses artificial intelligence to decode the genetic complexity of the human microbiome and identify biomarkers that predict treatment efficacy. Alphabiome’s mission is to unlock the full potential of the microbiome to transform how diseases are understood, diagnosed, and treated . Its proprietary technology enables large-scale, reference-free analysis of microbial DNA – converting trillions of untapped genetic fragments into actionable insights for drug development, clinical decision-making, and precision medicine.
Funding
Every round, secondary, debt facility or acquisition involving Alphabiome.ai that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in